Intent to Sole Source - Biolegend Oliogos

Description

{"description":" This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Biolegend. \n\n Acquisition Description: \n\n Custom Oligios needed by PACT team at CCE to do single cell copy number analysis with Tapestri instrument for CAR-T cell products to support clinical QC assay. \n\n The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-004813) by 12:00 PM eastern standard time on 05/08/2026 to: valerie.gregorio@nih.gov. \n\n All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. \n\n \n"} Solicitation Number: NOI-CC-OLAO-26-004813 Type: Special Notice Base Type: Special Notice NAICS: 325414 Classification Code: 6550 Response Deadline: 2026-05-08T12:00:00-04:00 Office Address: Bethesda, MD Place of Performance: Bethesda, Maryland, 20892